Many new investors see pharma shares priced below Rs 100 and think the stock is cheap. But a low share price does not mean a company is undervalued or safe. Some small pharma companies grow steadily, while others face weak earnings, low trading volume, debt, or regulatory problems.
Pharma penny stocks under Rs 100 are shares of small pharmaceutical companies trading below Rs 100. They can give exposure to the pharma sector with a small amount, but they also carry high volatility, liquidity risk, and sudden price swings. This guide explains what these stocks are, how to check them, and the mistakes to avoid before investing.
Last updated: 21 October 2026. Stock prices and financial data change every trading day. This article is for education only and does not recommend any specific stock.
Pharma penny stocks under Rs 100 are low-priced shares of small pharmaceutical or healthcare companies. A low price alone does not make a stock undervalued. Before investing, check earnings, debt, promoter holding, trading volume, liquidity, and exchange surveillance status. These stocks can move sharply in both directions.
Pharma penny stocks under Rs 100 are shares of pharmaceutical, biotech, or healthcare companies whose market price is below Rs 100. In India, the term penny stock usually means a low-priced share from a small or lesser-known company. It does not only mean a share that costs a few paise.
These companies may make generic medicines, active pharmaceutical ingredients, tablets, capsules, herbal products, or healthcare chemicals. Active pharmaceutical ingredients, or APIs, are raw materials used to make medicines.
A Rs 20 share is not automatically cheaper than a Rs 500 share. What matters is what you get for the price: sales, profits, growth, debt, cash flow, and prospects. This is why fundamental analysis matters more than the share price.
The table below shows pharma stocks trading below Rs 10 on 21 October 2026, based on data published by Upstox. These are examples for research, not recommendations.
Company | Share price | Market cap | Day volume | 52-week high | 52-week low |
Vaishali Pharma | Rs 7.35 | Rs 101.79 crore | 47,300 shares | Rs 11.15 | Rs 4.75 |
Vivimed Labs | Rs 6.33 | Rs 52.65 crore | 11,937 shares | Rs 29.40 | Rs 4.75 |
JFL Life Sciences | Rs 9.85 | Rs 34.15 crore | 6,000 shares | Rs 14.67 | Rs 8.55 |
These numbers show why liquidity matters. JFL Life Sciences traded only 6,000 shares on that day. If you want to sell a large number of shares, there may not be enough buyers at your price.
Some companies that often appear in pharma penny stock lists include Achyut Healthcare, Johnson Pharmacare, Nectar Lifesciences, Sudarshan Pharma Industries, and Pharmaids Pharmaceuticals. Their prices change daily, so check live market data before making any decision.
Use these steps to build your own research list:
Do not buy a stock only because it appears in a list. A list is only the starting point for research.
Read the company website, annual report, and latest investor presentation. Understand what the company sells and who buys it.
Ask these questions:
If you cannot explain the business in one simple line, avoid the stock.
Look at the last three to five years of financial results. Steady sales growth with stable or improving profits is a better sign than one strong quarter.
Be careful if sales are falling, the company reports repeated losses, or profits come only from one-time items. Also check operating cash flow. A company can show accounting profit but still struggle to collect payments from customers.
Debt is money a company has borrowed. Some debt is normal, but high debt becomes risky when profits fall, or interest costs rise.
Check these numbers:
A low-priced pharma stock with rising debt and weak cash flow needs extra caution.
The price-to-earnings ratio, or P/E, shows how much investors pay for every rupee of annual earnings.
P/E = Share price divided by earnings per share.
For example, if a stock trades at Rs 40 and earns Rs 2 per share in a year, its P/E is 20. Investors are paying Rs 20 for every Rs 1 of yearly earnings.
A low P/E does not always mean a bargain. It may mean the market expects profits to fall or sees higher risk. Use P/E with debt, growth, cash flow, and industry comparison.
Liquidity means how easily you can buy or sell shares without moving the price too much. This is one of the most important checks for penny stocks.
Look at:
If a stock trades only a few thousand shares a day, selling a large position during a fall can be difficult.
Promoters are the founders, main owners, or controlling shareholders. Their holdings can tell you something about confidence in the business.
Watch for promoters increasing their stake gradually, promoters pledging shares to borrow money, frequent promoter selling, or sudden changes in shareholding. A pledge means promoters have used their shares as security for a loan. If the share price falls sharply, lenders may ask for more security or sell the pledged shares.
ASM means Additional Surveillance Measure. SEBI and the exchanges use it for stocks showing unusual price movement, high volatility, or abnormal trading activity. A stock under ASM may face higher margins or other restrictions.
In simple words, if a stock rises or falls without a clear reason, exchanges may watch it more closely.
GSM means Graded Surveillance Measure. It is a stricter measure used when a stock price movement does not appear supported by fundamentals. Under GSM, trading restrictions can be tighter, and investors may need to pay the full trade value upfront.
A circuit limit is the maximum percentage a stock can rise or fall in one trading session. For example, if a stock has a 5 percent circuit and closes at Rs 50, it may not trade below Rs 47.50 or above Rs 52.50 the next day.
A lower circuit can create an exit problem. If there are only sellers and no buyers, your sell order may remain pending even though you want to exit.
In trade-to-trade settlement, every buy must be delivered, and every sell must be from shares you already hold. You cannot buy in the morning and sell the same shares on the same day.
Before trading any pharma penny stock, check whether it is in normal rolling settlement or trade-to-trade settlement.
Suppose you invest Rs 20,000 in a pharma penny stock trading at Rs 20 per share.
Detail | Calculation | Result |
Investment amount | Not applicable | Rs 20,000 |
Buy price | Not applicable | Rs 20 |
Number of shares | Rs 20,000 divided by Rs 20 | 1,000 shares |
Stock rises to Rs 26 | 1,000 multiplied by Rs 26 | Rs 26,000 |
Profit | Rs 26,000 minus Rs 20,000 | Rs 6,000 |
Return | Rs 6,000 divided by Rs 20,000 | 30 percent |
Now suppose the stock falls to Rs 14.
Detail | Calculation | Result |
New holding value | 1,000 multiplied by Rs 14 | Rs 14,000 |
Loss | Rs 20,000 minus Rs 14,000 | Rs 6,000 |
Return | Rs 6,000 divided by Rs 20,000 | 30 percent loss |
A Rs 6 fall may look small, but it is a 30 percent loss on your money. This is why position size matters more than the share price.
Liquidity can make the situation worse. If the stock has low volume, you may not be able to sell all 1,000 shares at Rs 14. You may have to wait, accept a lower price, or sell in smaller quantities.
Pharma penny stocks can be useful when chosen carefully:
Research and discipline matter more than the share price.
Small pharma companies may have unstable revenue, few products, or dependence on a few customers. Losing one major client or facing a quality issue can hurt earnings.
A stock may be easy to buy but hard to sell. Low trading volume and a wide gap between buy and sell prices can increase your real cost.
Penny stocks can move sharply without much news. Buying after a big rally or selling in panic after a fall often leads to poor results.
Low-priced, thinly traded shares can attract rumours and coordinated buying. If a stock rises sharply without any business update, treat it as a warning sign, not an opportunity.
Pharma companies need approvals, quality compliance, and sometimes export certifications. A negative inspection report, pricing rule, or regulatory action can affect both earnings and sentiment.
High debt, negative cash flow, falling sales, or repeated losses can make a low-priced stock risky even if it looks cheap. P/E alone cannot show debt or cash flow problems.
Many investors lose money not because they chose a bad stock, but because they invested too much, followed tips, averaged down without a plan, or refused to exit when the business worsened.
To buy and hold shares, you need a demat account. It holds your shares electronically, while a trading account lets you place buy and sell orders.
Parameter | Pharma penny stocks under Rs 100 | Established pharma stocks |
Share price | Usually below Rs 100 | Can be higher, but price alone does not show value |
Company size | Usually micro cap or small cap | Usually mid cap or large cap |
Liquidity | Can be low and exits may be difficult | Usually higher trading volumes |
Volatility | High | Usually lower, though sector news can still move prices |
Business visibility | Often limited | Usually stronger product range and financial history |
Research burden | High | Moderate to high |
Surveillance restrictions | More common | Less common |
What beginners should check | Volume, debt, promoter holding, ASM and GSM status | Valuation, growth, competitive position, and results |
Suitability | Experienced and risk-aware investors | Beginners and long-term investors may find them easier to study |
Pharma penny stocks under Rs 100 may suit investors who understand basic fundamental and technical analysis, can handle high volatility, have time to read results and filings, keep position sizes small, and are comfortable with lower liquidity.
They may not suit complete beginners, investors who need money back within a short period, people who cannot handle a 30 to 50 percent fall in a position, traders who depend on quick exits, or investors who buy based on social media tips.
Pharma penny stocks under Rs 100 can offer low-cost entry into the pharmaceutical sector, but their low price does not make them safe or undervalued. Check the business, earnings, debt, cash flow, promoter holding, trading volume, and exchange restrictions before investing.
For beginners, the safer approach is to invest small, diversify, avoid tips, and focus on companies with clear businesses and improving financials. Look at the business, financials, and exit plan, not just the share price.
Attention Investors!
Stock Brokers can accept securities as margin from clients only by way of pledge in the depository system w.e.f. September 1, 2020. Update your mobile number & email Id with your stock broker/depository participant and receive OTP directly from the depository on your email id and/or mobile number to create a pledge. Pay 20% upfront margin of the transaction early to trade in the cash market segment. Investors may please refer to the Exchange’s Frequently Asked Questions (FAQs) issued vide circular reference NSE/INSP/45191 dated July 31, 2020, and NSE/INSP/45534 dated August 31, 2020, and other guidelines issued from time to time in this regard. Check your Securities /MF/ Bonds in the consolidated account statement issued by NSDL/CDSL every month.
Corporate Office: No. 153/2, 3rd Floor, M.R.B.Arcade, Bagalur Main Road, Dwaraka Nagar, Yelahanka, Bengaluru – 560 063, Karnataka.
Registered Office: Old No.56/2 ,New No.58, LIC Nagar, Vinayagar Kovil Street, Erode -8,Tamil Nadu– 638002.
Alice Blue Financial Services (P) Ltd : NSE EQ | NSE FO | NSE CDS-90112 SEBI REG : INZ000156038
Alice Blue Financial Services (P) Ltd : BSE EQ | BSE FO | BSE CD-6670 SEBI REG : INZ000156038
Alice Blue Financial Services (P) Ltd : CDSL DP ID 12085300 DP SEBI REG : IN-DP-364-2018
Alice Blue Financial Services (P) Ltd : MCX-56710 SEBI REG : INZ000156038
We hereby declare that we are doing PRO trading
Procedure to file a complaint on SEBI SCORES : Register on SEBI SCORES 2.0. Mandatory details for filing complaints on SCORES: Name, PAN, Address, Mobile Number, E-mail ID. Benefits: Effective Communication, Speedy redressal of the grievances
Click on the provided link to learn about the process for submitting a complaint on the ODR platform for resolving investor grievances.
Investment in securities markets are subject to market risks, read all the related documents carefully before investing. Brokerage will not exceed SEBI prescribed limit.
For queries regarding account opening or activation, email to [email protected] and for fund updates, email to [email protected]
Disclaimer : Prevent unauthorized transactions in your account. Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors. All clients have to update their email id and mobile number with Member : Investor Grievance [email protected]
KYC is a one time exercise while dealing in securities markets – once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
No need to issue cheques by investors while subscribing to an IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in the investor’s account.
Investors are requested to note that Alice Blue Financial Services Private Limited is permitted to receive money from investor through designated bank accounts only named as Up streaming Client Nodal Bank Account (USCNBA). Alice Blue Financial Services Private Limited is also required to disclose these USCNB accounts to Stock Exchange. Hence, you are requested to use following USCNB accounts only for the purpose of dealings in your trading account with us. The details of these USCNB accounts are also displayed by Stock Exchanges on their website under “Know/ Locate your Stock Broker. Bank Details (Valid UPI FAQ).
